Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals
Open Access
- 29 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 67 (3), 638-651
- https://doi.org/10.1093/jac/dkr539
Abstract
To determine the antimicrobial susceptibility of Escherichia coli, Salmonella, Campylobacter and Enterococcus from cattle, pigs and chickens across the European Union (EU) using uniform methodology. Intestinal samples (1624) were taken at slaughter across five EU countries. Bacteria were isolated in national laboratories, whilst MICs were determined in a central laboratory for key antimicrobials used in human medicine. Clinical resistance was based on CLSI breakpoints and decreased susceptibility based on European Food Safety Authority (EFSA)/EUCAST epidemiological cut-off values. Isolation rates were high for E. coli (n = 1540), low for Salmonella (n = 201) and intermediate for Campylobacter (n = 940) and Enterococcus (n = 786). For E. coli and Salmonella, clinical resistance to newer compounds (cefepime, cefotaxime and ciprofloxacin) was absent or low, but decreased susceptibility was apparent, particularly in chicken strains. Resistance to older compounds (except gentamicin) was variable and higher. Colistin resistance was absent for E. coli, but apparent for Salmonella. For Campylobacter jejuni, ciprofloxacin resistance was markedly prevalent for chickens, whereas clinical resistance and decreased susceptibility to erythromycin was absent or very low. For Campylobacter coli, resistance was notably higher. None of the Enterococcus faecium strains was resistant to linezolid, but some were resistant to ampicillin or vancomycin. Resistance to quinupristin/dalfopristin was frequent. Resistance patterns varied widely depending on bacterial species, antibiotics, hosts and region. Resistance varied among countries, particularly for older antimicrobials, but clinical resistance to newer antibiotics used to treat foodborne disease in humans was generally very low. In the absence of resistance to newer compounds in E. coli and Salmonella, the apparent decreased susceptibility should be monitored.This publication has 22 references indexed in Scilit:
- Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU?International Journal of Antimicrobial Agents, 2011
- The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food‐borne Outbreaks in 2009EFSA Journal, 2011
- Supranational surveillance of antimicrobial resistance: The legacy of the last decade and proposals for the futureDrug Resistance Updates, 2010
- Assessing the antimicrobial susceptibility of bacteria obtained from animalsVeterinary Microbiology, 2010
- A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animalsJournal of Antimicrobial Chemotherapy, 2009
- The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in EuropeJournal of Antimicrobial Chemotherapy, 2005
- A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animalsJournal of Antimicrobial Chemotherapy, 2004
- Resistance surveillance studies--comparability of results and quality assurance of methods.Journal of Antimicrobial Chemotherapy, 2002
- Antimicrobial resistance: standardisation and harmonisation of laboratory methodologies for the detection and quantification of antimicrobial resistanceRevue Scientifique et Technique de l'OIE, 2001
- Antimicrobial resistance: harmonisation of national antimicrobial resistance monitoring and surveillance programmes in animals and in animal-derived foodRevue Scientifique et Technique de l'OIE, 2001